Viatris patent expiration

1. Geodon patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5312925 VIATRIS Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
Sep, 2012

(11 years ago)

US6245766 VIATRIS Method of treating psychiatric conditions
Dec, 2018

(5 years ago)

US6150366 VIATRIS Ziprasidone formulations
May, 2019

(5 years ago)




Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-615) Nov 20, 2012
M(M-232) Jan 28, 2025

Drugs and Companies using ZIPRASIDONE HYDROCHLORIDE ingredient

Market Authorisation Date: 05 February, 2001

Treatment: Treatment of bipolar disorder

Dosage: CAPSULE

How can I launch a generic of GEODON before it's drug patent expiration?
More Information on Dosage

GEODON family patents

Family Patents

2. Geodon patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6110918 VIATRIS Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist
Mar, 2017

(7 years ago)

US6232304 VIATRIS Inclusion complexes of aryl-heterocyclic salts
Apr, 2017

(7 years ago)

US6399777 VIATRIS Inclusion complexes of aryl-heterocyclic salts
Apr, 2017

(7 years ago)




Drugs and Companies using ZIPRASIDONE MESYLATE ingredient

Market Authorisation Date: 21 June, 2002

Treatment: NA

Dosage: POWDER

More Information on Dosage

GEODON family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Neurontin patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6054482 VIATRIS Lactam-free amino acids
Apr, 2017

(7 years ago)

US6054482

(Pediatric)

VIATRIS Lactam-free amino acids
Oct, 2017

(6 years ago)

US7256216 VIATRIS Liquid pharmaceutical compositions
May, 2022

(2 years ago)

US7256216

(Pediatric)

VIATRIS Liquid pharmaceutical compositions
Nov, 2022

(1 year, 7 months ago)




Drugs and Companies using GABAPENTIN ingredient

Market Authorisation Date: 30 December, 1993

Treatment: NA

Dosage: CAPSULE; TABLET; SOLUTION

How can I launch a generic of NEURONTIN before it's drug patent expiration?
More Information on Dosage

NEURONTIN family patents

Family Patents

4. Nitrostat patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6500456 VIATRIS Compressed nitroglycerin tablet and its method of manufacture
Sep, 2018

(5 years ago)




Drugs and Companies using NITROGLYCERIN ingredient

Market Authorisation Date: 01 May, 2000

Treatment: NA

Dosage: TABLET

How can I launch a generic of NITROSTAT before it's drug patent expiration?
More Information on Dosage

NITROSTAT family patents

Family Patents

5. Revatio patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5250534

(Pediatric)

VIATRIS Pyrazolopyrimidinone antianginal agents
Sep, 2012

(11 years ago)




Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-598) May 07, 2012
Pediatric Exclusivity(PED) Nov 07, 2012
M(M-61) Aug 30, 2015
M(M-133) Jan 31, 2017
New Dosing Schedule(D-137) Jan 31, 2017
M(M-287) Jan 31, 2026
Orphan Drug Exclusivity(ODE-469) Jan 31, 2030

Drugs and Companies using SILDENAFIL CITRATE ingredient

Market Authorisation Date: 03 June, 2005

Treatment: NA

Dosage: TABLET; SOLUTION

More Information on Dosage

REVATIO family patents

Family Patents

6. Viagra patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5250534

(Pediatric)

VIATRIS Pyrazolopyrimidinone antianginal agents
Sep, 2012

(11 years ago)

US6469012 VIATRIS Pyrazolopyrimidinones for the treatment of impotence
Oct, 2019

(4 years ago)

US6469012

(Pediatric)

VIATRIS Pyrazolopyrimidinones for the treatment of impotence
Apr, 2020

(4 years ago)




Drugs and Companies using SILDENAFIL CITRATE ingredient

Market Authorisation Date: 27 March, 1998

Treatment: Treatment of erectile dysfunction

Dosage: TABLET

How can I launch a generic of VIAGRA before it's drug patent expiration?
More Information on Dosage

VIAGRA family patents

Family Patents

7. Zoloft patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5248699 VIATRIS Sertraline polymorph
Aug, 2012

(11 years ago)

US5248699

(Pediatric)

VIATRIS Sertraline polymorph
Feb, 2013

(11 years ago)

US6727283 VIATRIS Sertraline oral concentrate
Oct, 2019

(4 years ago)

US7067555 VIATRIS Sertraline oral concentrate
Oct, 2019

(4 years ago)

US7067555

(Pediatric)

VIATRIS Sertraline oral concentrate
Apr, 2020

(4 years ago)

US6727283

(Pediatric)

VIATRIS Sertraline oral concentrate
Apr, 2020

(4 years ago)




Drugs and Companies using SERTRALINE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 December, 1991

Treatment: Treatment of disorders of the serotonergic system such as depression and anxiety-related disorders

Dosage: TABLET; CONCENTRATE

How can I launch a generic of ZOLOFT before it's drug patent expiration?
More Information on Dosage

ZOLOFT family patents

Family Patents